Ocugen, Inc. Profile Avatar - Palmy Investing

Ocugen, Inc.

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function…

Biotechnology
US, Malvern [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of OCGN's Analysis
CIK: 1372299 CUSIP: 67577C105 ISIN: US67577C1053 LEI: - UEI: -
Secondary Listings
OCGN has no secondary listings inside our databases.